Thieler Law Corp advises investors with losses exceeding $100,000 of the March 18, 2019 lead plaintiff deadline in a class action lawsuit filed against DBV Technologies S.A. (NASDAQ: DBVT) (“DBV Technologies” or “the Company”). The suit is pending in the U.S. District Court for the District of New Jersey and investors, who purchased DBV Technologies S.A. securities between February 14, 2018 and December 19, 2018, have until March 18, 2019 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class.

If you purchased DBV Technologies S.A. securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com . No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class.

The complaint alleges that during the Class Period defendants made false and misleading statements and/or allegedly failed to disclose that DBV Technologies' Biologics License Application ("BLA") for Viaskin Peanut failed to provide the FDA with sufficient data on manufacturing procedures and quality controls; consequently, DBV Technologies voluntarily withdrew the BLA for Viaskin Peanut; and as a result, defendants' statements about DBV Technologies' business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.

On December 19, 2018, the Company revealed that its BLA for Viaskin Peanut had been voluntarily withdrawn following discussions with the FDA. According to the Company, ''although the agency did not reference any medical or clinical questions with the submission of Viaskin Peanut, the FDA did communicate that the level of detail with regards to data on manufacturing and quality controls was insufficient in the BLA.''

Following this news NASDAQ: DBVT fell $8.39 or nearly 60% to close at $5.76 on December 20, 2018.

If you were negatively impacted by your investment in DBV Technologies S.A. securities between February 14, 2018 and December 19, 2018 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm. Materials are provided for informational purposes only and do not constitute legal advice. We are only licensed to practice law in Germany. We are neither licensed nor qualified to render advice on US Federal or State law.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/

or

Facsimile: +1 (619) 785 – 3185